Incorporation of extracorporeal photopheresis into a reduced intensity conditioning regimen in myelodysplastic syndrome and aggressive lymphoma: results from ECOG 1402 and 1902.
CONCLUSIONS: These studies demonstrate that ECP/pentostatin/TBI is well tolerated and associated with adequate engraftment of neutrophils and platelets in patients with lymphomas and MDS.
PMID: 32654201 [PubMed - as supplied by publisher]
Source: Transfusion - Category: Hematology Authors: Foss FM, Wang XV, Luger SM, Jegede O, Miller KB, Stadtmauer EA, Whiteside TL, Avigan DE, Gascoyne RD, Arber D, Wagner H, Strair RK, Hogan WJ, Sprague KA, Lazarus HM, Litzow MR, Tallman MS, Horning SJ Tags: Transfusion Source Type: research
More News: Hematology | Lymphoma | Methotrexate | Myelodysplastic Syndrome | Prograf | Restasis | Stem Cell Therapy | Stem Cells | Study | Tacrolimus